
No Decision for Me Without Me: Embedding Patient Expertise at the Heart of Innovation
200
PATIENT ADVOCATES
400
C-LEVEL PARTICIPANTS
400
ATTENDEES
* Based on 2025

The Galien Patient Summit creates a collaborative platform where patient voices, experiences, and needs directly shape the future of medical research, drug development, and healthcare delivery. For the second year, the Galien Patient Summit will take place concurrently with the annual Galien USA Forum - the premiere industry meeting of the minds on the future of human health.

In the program Galien Forum 2023
Thursday Oct. 26, 2023
Preliminary Program
PANEL 1
Breakthroughs & Blind Spots:
What Will Today’s Consensus Regret Tomorrow?
PANEL 2
Medical Triumph vs Pricing Paradox:
Can We Afford the Medicines We’re Capable of Creating?
PANEL 3
20 Years in 20 Minutes:
A History of Breakthroughs + Lessons for the Next 2 Decades
PANEL 4
The Biology We Still Don’t Understand:
Frontiers That Will Define the Next 20 Years
PANEL 5
Life Science Diplomacy & Scientific Sovereignty:
Strategy for the Next 20 Years
PANEL 6 I CEO PANEL
Biopharma Leaders:
Leading the Leap
FIRESIDE CHAT
FDA Commissioner
(1 Year Later)
PANEL 7
The Science Trust Conundrum:
When Society Doubts Its Own Progress

Promise & Reality:
Decoding AI’s Impact on Drug Development

PANEL 2
Advancing the Pipeline:
Ensuring Academic and Government Discoveries are Translated for Medical Impact

Therapeutic Area Advances and Challenges (mRNA & CRISPR): Getting Gene Therapy Innovation to a Critical Mass of Patients

Fireside Chat with Alex Gorsky

PANEL 4a
AI's Impact on Personal and Public Health -- Now & in the Future
.png?width=282&height=153&name=PANEL%20OBESITY%20SCIENCE%20(1).png)
PANEL 4b
Advancing Brain Health: Innovations and Insights for a Healthier Future

How to Build a Paradigm-Transforming Blockbuster
Who will be speaking in 2026
Confirmed Speakers (as of June 18, 2026)
Jeremy Abbate
Vice President & Publisher, Scientific American
Amy P. Abernethy
Co-Founder, Highlander Health; former Principal Deputy Commissioner, FDA
Gil Bashe
Chair of Global Health & Purpose, Finn Partners
Michaela Dinboeck
Head Patient Engagement, Novartis
David Fajgenbaum
Co-Founder, Every Cure; Professor, University of Pennsylvania
Julie Fleshman
CEO, Pancreatic Cancer Action Network
Atul A. Gawande
Fish Chair in Surgery, Brigham and Women’s Hospital; Samuel O. Thier Professor of the Practice, Harvard Medical School; Distinguished Professor in Residence, Ariadne Labs
Atul A. Gawande
Fish Chair in Surgery, Brigham and Women’s Hospital; Samuel O. Thier Professor of the Practice, Harvard Medical School; Distinguished Professor in Residence, Ariadne Labs
Kathy Giusti
Founder, Multiple Myeloma Research Foundation; Author, Fatal to Fearless
Jennifer Goldsack
CEO, Digital Medicine Society (DiMe)
Margaret Hamburg
Co-President, InterAcademy Partnership; Former Commissioner, US Food and Drug Administration
Daphne Koller
CEO & Founder, insitro
Jeremy Levin
Chairman & CEO, Ovid Therapeutics
Thomas Lines
CEO, Quercis
Cheryl Lubbert
Chief Executive Officer, Reverba Global
Vardit Ravitsky
President, Hastings Center for Bioethics
Kate Sasser
Chief Scientific Officer, Tempus
Sheri Strahl
President & CEO, ALS Network
Janet Woodcock
Former Principal Deputy Commissioner, FDA and longtime Director, Center for Drug Evaluation and Research
TOP SCIENTISTS & KOL
Interested in seeing who has spoken at our events? Check out our impressive roster of Top Scientists and Key Opinion Leaders.
PREVIOUS DEBATES









